X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (117) 117
index medicus (91) 91
female (81) 81
infectious diseases (67) 67
adult (61) 61
middle aged (52) 52
male (47) 47
urinary tract infections (44) 44
aged (39) 39
microbiology (36) 36
antibiotics (33) 33
asymptomatic bacteriuria (33) 33
risk factors (31) 31
health aspects (27) 27
netherlands (27) 27
infections (25) 25
women (25) 25
adolescent (24) 24
anti-bacterial agents - therapeutic use (24) 24
risk-factors (24) 24
immunology (22) 22
urinary tract infections - drug therapy (22) 22
urinary tract infection (21) 21
research (20) 20
young adult (20) 20
care and treatment (19) 19
diabetes mellitus (18) 18
hiv (18) 18
medicine (18) 18
medicine, general & internal (18) 18
epidemiology (17) 17
research article (17) 17
escherichia-coli (16) 16
management (16) 16
netherlands - epidemiology (16) 16
internal medicine (15) 15
pregnancy (15) 15
treatment outcome (15) 15
urinary tract infections - epidemiology (15) 15
aged, 80 and over (14) 14
diagnosis (14) 14
guidelines (14) 14
infection (14) 14
patients (14) 14
prevention (14) 14
urinary tract infections - prevention & control (14) 14
usage (14) 14
analysis (13) 13
diabetes (13) 13
prevalence (13) 13
urogenital system (13) 13
antiretroviral therapy (12) 12
bacteriuria (12) 12
drug resistance in microorganisms (12) 12
hospitals (12) 12
mortality (12) 12
population (12) 12
pyelonephritis (12) 12
resistance (12) 12
therapy (12) 12
bacteriuria - complications (11) 11
drug resistance (11) 11
urine (11) 11
bacteriuria - microbiology (10) 10
cohort studies (10) 10
diabetes complications (10) 10
human immunodeficiency virus--hiv (10) 10
incidence (10) 10
multidisciplinary sciences (10) 10
science (10) 10
studies (10) 10
urinary tract diseases (10) 10
urinary tract infections - complications (10) 10
urinary tract infections - diagnosis (10) 10
urinary-tract-infections (10) 10
antimicrobial agents (9) 9
care (9) 9
cystitis (9) 9
double-blind (9) 9
hiv infections - drug therapy (9) 9
medical research (9) 9
pharmacology & pharmacy (9) 9
primary health care (9) 9
urinary tract infections - microbiology (9) 9
virology (9) 9
bacteria (8) 8
cost-benefit analysis (8) 8
drug resistance, bacterial (8) 8
hiv infection (8) 8
hiv infections - epidemiology (8) 8
impact (8) 8
intervention (8) 8
outcomes (8) 8
prospective studies (8) 8
quality improvement (8) 8
retrospective studies (8) 8
risk (8) 8
susceptibility (8) 8
urinary tract (8) 8
acute pyelonephritis (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Boerekamps, A and Newsum, Astrid M and Smit, C and Arends, Joop and Richter, C and Reiss, Peter and Rijnders, Bart and Brinkman, K and Valk, Marc and Geerlings, Suzanne and Godfried, M.H and Goorhuis, Abraham and Hovius, Joppe and Meer, J. T M and Kuijpers, Taco W and Nellen, F. J B and Van Der Poll, D.T and Prins, Jan and Van Vugt, H.J.M and Wiersinga, W.J and Wit, Ferdinand and Van Duinen, M and Van Eden, J and Van Hes, A.M.H and Mutschelknauss, M and Nobel, H.E and Pijnappel, F.J.J and Weijsenfeld, A.M and Jurriaans, Suzanne and Back, Nicole and Zaaijer, Hans and Berkhout, Ben and Cornelissen, Marion and Schinkel, C.J and Wolthers, Katja and Van Den Berge, M and Stegeman, A and Baas, S and Hage De Looff, L and Wintermans, B and Veenemans, J and Pronk, Marjolijn and Ammerlaan, Heidi and De Munnik, E.S and Jansz, A.R and Tjhie, J and Wegdam, M.C.A and Deiman, B and Scharnhorst, V and Eeden, Arne and Brokking, W and Groot, Marieke and Elsenburg, L.J.M and Damen, M and Kwa, I.S and Kasteren, Marjo and Brouwer, A.E and Van Erve, R and De Kruijf-Van De Wiel, B.A.F.M and Keelan-Pfaf, S and Van Der Ven, B and Van Der Ven, B and Buiting, Anton and Kabel, P.J and Versteeg, D and Ende, Marchina and Bax, Hannelore and Gorp, Eric and Nouwen, Jan and Schurink, Carolina and Verbon, Annelies and Vriessluijs, Theodora and De Jong-Peltenburg, N.C and Bassant, N and Van Beek, J.E.A and Vriesde, M and van Zonneveld, Laura and Van Den Berg-Cameron, H.J and Groot, Jan Cees and De Zeeuw-De Man, M and Boucher, Charles and Koopmans, Marion and Kampen, Jeroen and Pas, Suzan and Branger, J and Rijkeboer-Mes, A and Duijf-Van De Ven, C.J.H.M and Schippers, E.F and Nieuwkoop, Cees and Van IJperen, J.M and Geilings, J and Van Der Hut, G and Burgel, Nathalie and Leyten, Eliane and Gelinck, Luc and Van Hartingsveld, A.Y and Meerkerk, C and Wildenbeest, G.S and Heikens, E and Groeneveld, P.H.P and ... and Netherlands ATHENA HIV Observation and NVHB-SHM Hepatitis Working Grp and NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort
Clinical Infectious Diseases, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, pp. 1352 - 1359
markdownabstractBackground The Netherlands has provided unrestricted access to direct-acting antivirals (DAAs) since November 2015. We analyzed the nationwide... 
Treatment uptake | HIV/HCV coinfection | Direct-acting antivirals | treatment uptake | INFECTIOUS DISEASES | EFFICACY | SAFETY | SEX | MICROBIOLOGY | IMMUNOLOGY | direct-acting antivirals | INDIVIDUALS | HIV | REINFECTION | MEN | INFECTION | COHORT | AMSTERDAM
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 11, pp. 1324 - 1333
Journal Article
PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 9, p. e0184200
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 06/2019, Volume 19, Issue 6, pp. 562 - 564
Another interesting point is patient censoring during the 7-day follow-up due to removal of the catheter.7 In the control period, a lower percentage of... 
INFECTIOUS DISEASES | CARE-ASSOCIATED INFECTIONS | Urine | Intervention | Medical instruments | Urinary tract | Risk analysis | Catheters | Developing countries--LDCs | Risk factors | Incidence | Prevention | Infectious diseases | Antibiotics | Population | Urinary tract infections | Chlorhexidine | Urogenital system
Journal Article
PLoS ONE, ISSN 1932-6203, 2014, Volume 9, Issue 4, p. e91939
Urinary tract infections (UTIs) are common and result in an enormous economic burden. The increasing prevalence of antibiotic-resistant microorganisms has... 
IMPUTATION | TRIMETHOPRIM | MULTIDISCIPLINARY SCIENCES | ESCHERICHIA-COLI | RESISTANCE | VALIDATION | JUICE | HEALTH | CONSUMPTION | Anti-Bacterial Agents - economics | Recurrence | Premenopause | Humans | Middle Aged | Antibiotic Prophylaxis | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Urinary Tract Infections - economics | Urinary Tract Infections - prevention & control | Beverages - economics | Vaccinium macrocarpon | Young Adult | Anti-Bacterial Agents - therapeutic use | Urinary Tract Infections - epidemiology | Trimethoprim, Sulfamethoxazole Drug Combination - economics | Cost-Benefit Analysis | Adult | Female | Care and treatment | Menopause | Clinical trials | Urinary tract infections | Drug therapy | Antibacterial agents | Health aspects | Risk factors | Infection control | Health care | Costs | Prophylaxis | Trimethoprim | Infections | Urinary tract | Dosage | Drug resistance | Cranberries | Confidence intervals | Trimethoprim-sulfamethoxazole | Sulfamethoxazole | Microorganisms | Randomization | Planes | Antibiotic resistance | Urogenital system | Drug dosages | Urine | Anticoagulants | Statistical analysis | Internal medicine | Berries | Antimicrobial agents | Urinary tract diseases | Quality of life | Disease prevention | Studies | Missing data | Infectious diseases | Antibiotics | Womens health | Cost analysis
Journal Article
BMC infectious diseases, ISSN 1471-2334, 12/2018, Volume 18, Issue 1, pp. 626 - 8
BACKGROUND: Febrile Urinary Tract Infection (FUTI) is frequently treated initially with intravenous antibiotics, followed by oral antibiotics guided by... 
Anti-Bacterial Agents/administration & dosage | Double-Blind Method | Administration, Oral | Humans | Middle Aged | Escherichia coli Infections/complications | Fosfomycin/administration & dosage | Escherichia coli/drug effects | Young Adult | Administration, Intravenous | Fever/complications | Urinary Tract Infections/complications | Adolescent | Aged, 80 and over | Placebos | Adult | Female | Aged | Equivalence Trials as Topic | Ciprofloxacin/administration & dosage | INFECTIOUS DISEASES | Randomized clinical trial | ESCHERICHIA-COLI | SUSCEPTIBILITY | GUIDELINES | Antibiotic treatment | Scherichia coli | RESISTANT | Urinary tract infection | THERAPY | PYELONEPHRITIS | LEVOFLOXACIN | Fosfomycin-trometamol | SWITCH | Escherichia coli - drug effects | Fever - complications | Urinary Tract Infections - complications | Anti-Bacterial Agents - adverse effects | Escherichia coli Infections - drug therapy | Ciprofloxacin - adverse effects | Fosfomycin - adverse effects | Urinary Tract Infections - drug therapy | Fosfomycin - administration & dosage | Ciprofloxacin - administration & dosage | Anti-Bacterial Agents - administration & dosage | Fever - drug therapy | Escherichia coli Infections - complications | Drug resistance in microorganisms | Usage | Analysis | Mortality | Urinary tract infections | Chemical properties | Ciprofloxacin | Health aspects | Fosfomycin | Intravenous administration | Clinical trials | Population studies | Systematic review | Infections | Urinary tract | Absenteeism | Drug resistance | Trometamol | Randomization | Pain | E coli | Bacteria | Urogenital system | Electrical impedance | Urine | Women | Bacterial infections | Antimicrobial agents | Patients | Bactericidal activity | Urinary tract diseases | Antibiotics | Internet
Journal Article
Journal Article